Product Approval Information
Proper Name: Zoster Vaccine, Live
Tradename: Zostavax
Manufacturer: Merck & Co., Inc, License #0002
- Package Insert (PDF - 136 KB) - July, 2007
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
Date: May 25, 2006
Indication: Prevention of herpes zoster (shingles) in individuals 60 years of age and older when administered as a single-dose
- May 25, 2006 Approval Letter
- Patient Information (PDF - 40 KB)
- Patient Information (Text)
- Questions and Answers
- FDA News Release
Date: July 6, 2007
Revised Package Insert: To include a statement in the package insert regarding concomitant administration of ZOSTAVAX with inactivated influenza vaccine